Carson Wealth (CWM LLC)’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$66.4K Buy
690
+33
+5% +$3.3K ﹤0.01% 3596
2025
Q4
$64K Buy
657
+107
+19% +$9.18K ﹤0.01% 3418
2025
Q3
$39K Buy
550
+211
+62% +$14.1K ﹤0.01% 3718
2025
Q2
$20K Sell
339
-325
-49% -$17.8K ﹤0.01% 3907
2025
Q1
$35K Buy
664
+33
+5% +$1.85K ﹤0.01% 3260
2024
Q4
$35K Buy
631
+442
+234% +$23.3K ﹤0.01% 3057
2024
Q3
$10K Buy
189
+71
+60% +$3.28K ﹤0.01% 3787
2024
Q2
$5K Buy
118
+87
+281% +$3.7K ﹤0.01% 3876
2024
Q1
$1K Sell
31
-29
-48% -$1.28K ﹤0.01% 4151
2023
Q4
$3K Sell
60
-60
-50% -$2.52K ﹤0.01% 3708
2023
Q3
$5K Buy
120
+115
+2,300% +$5.34K ﹤0.01% 3467
2023
Q2
$0 Buy
+5
New +$225 ﹤0.01% 4315

Other funds holding IRMD

Carson Wealth (CWM LLC)'s IRMD Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its iRadimed (IRMD) stake by 5% in Q1 2026, buying an estimated $3.3K and bringing the position to 690 shares worth $66.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3596.

Carson Wealth (CWM LLC) first reported a position in IRMD in Q2 2023 and has held it in 12 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Carson Wealth (CWM LLC) held 690 shares of iRadimed worth $66.4K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 33 iRadimed shares in Q1 2026, an estimated $3.3K.
  • iRadimed made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3596 holding.
  • Carson Wealth (CWM LLC) first reported a position in iRadimed in Q2 2023 and has held it in 12 quarters since.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.